期刊文献+

从大气下陷论治肺癌化疗后病证 被引量:7

Treatment of Lung Cancer after Chemotherapy Based on Grand Qi Sinking
下载PDF
导出
摘要 大气下陷理论源于《医学衷中参西录》,涵盖宗气下陷证及中气下陷证。肺癌化疗后出现疲乏、气短、出汗、腹泻、纳差等症状可归为大气下陷证,用单纯补气的方法收效甚微。升陷汤是大气下陷证的代表方剂,临床用于治疗肺癌化疗后病证常能收到良好的疗效。肺癌化疗后病证治疗时推广应用大气下陷理论,为肺癌患者提高化疗后生活质量,确保化疗周期的顺利通过,提供了思路与方法。 The theory of grand qi sinking originates from Records of Chinese Medicine with Reference to Western Medicine,which covers the syndrome of pectoral qi sinking and center qi sinking. After chemotherapy,there would be symptoms like the fatigue,shortness of breath,sweating,diarrhea,anorexia and other symptoms,which all could be classified as grand qi sinking syndrome,and therefore to treat this syndrome treatment of tonifying qi alone usually fails in clinic. Shengxian decoction is the representative formula for qi sinking. It could achieve good curative effects in the treatment of lung cancer after chemotherapy. The theory of grand qi sinking should be widely applied in the treatment of lung cancer after chemotherapy. It provides ideas and methods for improving the quality of life of patients with lung cancer and ensuring the fulfillment of chemotherapy.
作者 吴钱生 李蒙丽 夏孟蛟 祝捷 由凤鸣 严然 WU Qiansheng;LI Mengli;XIA Mengjiao;ZHU Jie;YOU Fengming;YAN Ran(College of Clinical Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China)
出处 《山东中医杂志》 2019年第3期221-224,共4页 Shandong Journal of Traditional Chinese Medicine
基金 四川省科技厅项目(编号:2017SZ0077) 成都中医药大学校基金项目(编号:ZRQN1628)
关键词 大气下陷 肺癌 化疗后 病证 升陷汤 grand qi sinking lung cancer after chemotherapy disease and syndrome Shengxian decoction
  • 相关文献

参考文献3

二级参考文献34

  • 1刘贤臣,唐茂芹,胡蕾,王爱祯,吴宏新,赵贵芳,高春霓,李万顺.匹兹堡睡眠质量指数的信度和效度研究[J].中华精神科杂志,1996,29(2):103-107. 被引量:3442
  • 2Egeblad M,Werb Z.New functions for the matrix metallo proteinases in cancer progression.Nat Rev Cancer,2002(2): 161 - 174.
  • 3Leinonen T,Pirinen R,Bohm J,et al.Increased expression of matrixmetallo proteinase-(MMP2) predicts tumour recurrence and unfavourable outcome in non-small cell lung eaneer.Histol Histopathol, 2008(23):693-700.
  • 4Nakamura H,Ueno H,Yamash ita K,et al.Enhanced production and activation of progelatinase A mediated by membrane type E matfixmetallo proteinase in human papillary thyroid carcinomas. Cancer Res, 1999,59(2):467-473.
  • 5Chen P N,Hsieh Y S,Chiou H L,et al.Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.J Chem Bio Interac,2005,156(2-3): 141 - 150.
  • 6Weinstein-Oppenheimer C R,Blalock W L,Steelman L S,et al.The raf signal transducfion cascade as a target for chemotherapeutic intervention in growth factor-responsive tumour.J Pharmacol Ther,2000,88(3):229-279.
  • 7Westermarck J.Regulation of matrix metalloproteinase expression in tumor invasionJ Faser,1999,13(8):781-792.
  • 8Mccubrey J A,Steelman L S,Chappell W H,et al.Roles of the Raf/ MEK/ERK pathway in cell growth,malignant transformation and drug resistance.J Biochim Biophys Acta,2007,1773(8): 1263-1284.
  • 9Hsiao Y C,Kuo W H,Chen P N,et al.Flavanone and 29-OH flavanone inhibitmetastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway.J Chem Bio Interact, 2007,167(3): 193-206.
  • 10Liu H G,Zang C B,Anna E,et al.Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Clin Pharmacol,2008(591):43-51.

共引文献67

同被引文献149

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部